Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes

被引:8
|
作者
O'Brien, Matthew J. [1 ,2 ,3 ]
Bullard, Kai McKeever [4 ]
Zhang, Yan [4 ]
Gregg, Edward W. [4 ]
Carnethon, Mercedes R. [3 ]
Kandula, Namratha R. [1 ,2 ,3 ]
Ackermann, Ronald T. [1 ,2 ]
机构
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA
[2] Northwestern Univ, Inst Publ Hlth & Med, Feinberg Sch Med, Ctr Community Hlth, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA
关键词
diabetes screening; prediabetes; undiagnosed diabetes; diabetes; dysglycemia; LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; FOLLOW-UP; GLYCEMIC CONTROL; ADULTS; RISK; CARE; COMPLICATIONS; THRESHOLDS; PREVALENCE;
D O I
10.1007/s11606-018-4436-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In 2015, The US Preventive Services Task Force (USPSTF) recommended screening for prediabetes and undiagnosed diabetes (collectively called dysglycemia) among adults aged 40-70 years with overweight or obesity. The recommendation suggests that clinicians consider screening earlier in people who have other diabetes risk factors. To compare the performance of limited and expanded screening criteria recommended by the USPSTF for detecting dysglycemia among US adults. Cross-sectional analysis of survey and laboratory data collected from nationally representative samples of the civilian, noninstitutionalized US adult population. A total of 3643 adults without diagnosed diabetes who underwent measurement of hemoglobin A1c (A1c), fasting plasma glucose (FPG), and 2-h plasma glucose (2-h PG). Screening eligibility according to the limited criteria was based on age 40 to 70 years old and overweight/obesity. Screening eligibility according to the expanded criteria was determined by meeting the limited criteria or having ae<yen> 1 of the following risk factors: family history of diabetes, history of gestational diabetes or polycystic ovarian syndrome, and non-white race/ethnicity. Dysglycemia was defined by A1c ae<yen> 5.7%, FPG ae<yen> 100 mg/dL, and/or 2-h PG ae<yen> 140 mg/dL. Among the US adult population without diagnosed diabetes, 49.7% had dysglycemia. Screening based on the limited criteria demonstrated a sensitivity of 47.3% (95% CI, 44.7-50.0%) and specificity of 71.4% (95% CI, 67.3-75.2%). The expanded criteria yielded higher sensitivity [76.8% (95% CI, 73.5-79.8%)] and lower specificity [33.8% (95% CI, 30.1-37.7%)]. Point estimates for the sensitivity of the limited criteria were lower in all minority groups and significantly different for Asians compared to non-Hispanic whites [29.9% (95% CI, 23.4-37.2%) vs. 49.8% (95% CI, 45.9-53.7%); P < .001]. Diabetes screening that follows the limited USPSTF criteria will identify approximately half of US adults with dysglycemia. Screening other high-risk subgroups defined in the USPSTF recommendation would improve detection of dysglycemia and may reduce associated racial/ethnic disparities.
引用
收藏
页码:1100 / 1108
页数:9
相关论文
共 50 条
  • [31] Screening for gonorrhea: Recommendation statement - US Preventive Services Task Force
    Calonge, N
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (09) : 1783 - 1786
  • [32] Screening for Osteoporosis: US Preventive Services Task Force Recommendation Statement
    Nordin, Christopher
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (04) : 276 - 276
  • [33] Reframing the US Preventive Services Task Force Recommendations on Screening for Glaucoma
    Parrish, Richard K., II
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (05) : 860 - 862
  • [34] Screening for Preeclampsia US Preventive Services Task Force Recommendation Statement
    Bibbins-Domingo, Kirsten
    Grossman, David C.
    Curry, Susan J.
    Barry, Michael J.
    Davidson, Karina W.
    Doubeni, Chyke A.
    Epling, John W., Jr.
    Kemper, Alex R.
    Krist, Alex H.
    Kurth, Ann E.
    Landefeld, C. Seth
    Mangione, Carol M.
    Phillips, William R.
    Phipps, Maureen G.
    Silverstein, Michael
    Simon, Melissa A.
    Tseng, Chien-Wen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (16): : 1661 - 1667
  • [35] Lead screening update from the US Preventive Services Task Force
    Jacobs, David E.
    JOURNAL OF PEDIATRICS, 2019, 212 : 243 - 243
  • [36] U.S. Preventive Services Task Force Criteria for Diabetes Screening Time to Revisit the Evidence?
    Aroda, Vanita R.
    Fonseca, Vivian A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2013, 45 (02) : 246 - 247
  • [37] US Preventive Services Task Force. Screening for preeclampsia: US Preventive Services Task Force recommendation statement (vol 317, pg 1661, 2017)
    Bibbins-Domingo, K.
    Grossman, D. C.
    Curry, S. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (08): : 833 - 833
  • [38] Screening for Gestational Diabetes Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
    Pillay, Jennifer
    Donovan, Lois
    Guitard, Samantha
    Zakher, Bernadette
    Gates, Michelle
    Gates, Allison
    Vandermeer, Ben
    Bougatsos, Christina
    Chou, Roger
    Hartling, Lisa
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (06): : 539 - 562